(-1.57%) 5 035.69 points
(-1.49%) 37 816 points
(-2.04%) 15 658 points
(-0.95%) $81.15
(-2.16%) $1.948
(-0.26%) $2 296.80
(0.19%) $26.71
(-0.45%) $943.90
(0.13%) $0.938
(0.28%) $11.13
(0.15%) $0.801
(0.00%) $93.45
0.22% HKD 9.23
Live Chart Being Loaded With Signals
The United Laboratories International Holdings Limited, an investment holding company, engages in the research, development, manufacture, distribution, and sale of pharmaceutical products...
Stats | |
---|---|
Dzisiejszy wolumen | 2.85M |
Średni wolumen | 4.02M |
Kapitalizacja rynkowa | 16.77B |
EPS | HKD0 ( 2024-03-26 ) |
Last Dividend | HKD0.131 ( 2023-09-14 ) |
Next Dividend | HKD0 ( N/A ) |
P/E | 5.63 |
ATR14 | HKD0.00700 (0.08%) |
Wolumen Korelacja
United Laboratories Korelacja
10 Najbardziej pozytywne korelacje |
---|
10 Najbardziej negatywne korelacje |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
United Laboratories Korelacja - Waluta/Towar
United Laboratories Finanse
Annual | 2023 |
Przychody: | HKD13.74B |
Zysk brutto: | HKD6.33B (46.11 %) |
EPS: | HKD1.490 |
FY | 2023 |
Przychody: | HKD13.74B |
Zysk brutto: | HKD6.33B (46.11 %) |
EPS: | HKD1.490 |
FY | 2022 |
Przychody: | HKD11.33B |
Zysk brutto: | HKD4.97B (43.84 %) |
EPS: | HKD0.870 |
FY | 2021 |
Przychody: | HKD9.70B |
Zysk brutto: | HKD4.21B (43.40 %) |
EPS: | HKD0.560 |
Financial Reports:
No articles found.
United Laboratories Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
HKD0.0801 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0.196 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | HKD0.156 | 2008-05-26 |
Last Dividend | HKD0.131 | 2023-09-14 |
Next Dividend | HKD0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 15 | -- |
Total Paid Out | HKD1.398 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 2.66 | -- |
Div. Sustainability Score | 10.00 | |
Div.Growth Potential Score | 4.52 | |
Div. Directional Score | 7.71 | -- |
Year | Amount | Yield |
---|
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
9909.HK | Ex Dividend Knight | 2023-11-24 | Semi-Annually | 0 | 0.00% | |
2161.HK | Ex Dividend Junior | 2023-08-15 | Annually | 0 | 0.00% | |
1161.HK | Ex Dividend Knight | 2023-06-12 | Annually | 0 | 0.00% | |
0239.HK | Ex Dividend Knight | 2023-09-29 | Semi-Annually | 0 | 0.00% | |
3866.HK | Ex Dividend Junior | 2023-06-02 | Annually | 0 | 0.00% | |
1731.HK | Ex Dividend Junior | 2023-06-23 | Sporadic | 0 | 0.00% | |
0771.HK | Ex Dividend Knight | 2023-05-31 | Sporadic | 0 | 0.00% | |
2327.HK | Ex Dividend Junior | 2023-08-03 | Sporadic | 0 | 0.00% | |
1290.HK | Ex Dividend Junior | 2023-06-14 | Sporadic | 0 | 0.00% | |
0363.HK | Ex Dividend Knight | 2023-06-01 | Annually | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.197 | 1.500 | 6.07 | 9.10 | [0 - 0.5] |
returnOnAssetsTTM | 0.129 | 1.200 | 5.72 | 6.86 | [0 - 0.3] |
returnOnEquityTTM | 0.223 | 1.500 | 8.64 | 10.00 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 2.08 | 0.800 | 4.60 | 3.68 | [1 - 3] |
quickRatioTTM | 1.528 | 0.800 | 5.72 | 4.57 | [0.8 - 2.5] |
cashRatioTTM | 0.643 | 1.500 | 7.54 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.0714 | -1.500 | 8.81 | -10.00 | [0 - 0.6] |
interestCoverageTTM | 0 | 1.000 | -1.111 | -1.111 | [3 - 30] |
operatingCashFlowPerShareTTM | 0.659 | 2.00 | 9.78 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 0.400 | 2.00 | 9.80 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.118 | -1.500 | 9.53 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.461 | 1.000 | 5.65 | 5.65 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.231 | 1.000 | 7.38 | 7.38 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.798 | 1.000 | 6.68 | 6.68 | [0.2 - 2] |
assetTurnoverTTM | 0.654 | 0.800 | 8.98 | 7.18 | [0.5 - 2] |
Total Score | 10.90 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 5.74 | 1.000 | 9.52 | 0 | [1 - 100] |
returnOnEquityTTM | 0.223 | 2.50 | 9.12 | 10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 0.400 | 2.00 | 9.87 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 2.30 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 0.659 | 2.00 | 9.78 | 10.00 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | 0.101 | 1.500 | -2.66 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.0872 | 1.000 | -0.321 | 0 | [0.1 - 0.5] |
Total Score | 4.52 |
United Laboratories
The United Laboratories International Holdings Limited, an investment holding company, engages in the research, development, manufacture, distribution, and sale of pharmaceutical products. It operates through three segments: Bulk Medicine, Intermediate Products, and Finished Products. The company offers oral antibiotics, antimicrobials for injection, anti-cold products, cough medicines, ophthalmic drugs, antiviral drugs, anti-hepatitis B drugs, diabetes drugs, skin drugs for external use, cardiovascular and cerebrovascular drugs, nervous system drugs, vitamins, and vacant gelatin capsules, as well as API and intermediate products. It also manufactures and sells soft capsules casings; holds trademarks; and trades in pharmaceutical products. In addition, the company provides management services. It has operations in the People's Republic of China, Europe, India, the Middle East, South America, other Asian regions, and internationally. The company was founded in 1990 and is headquartered in Yuen Long, Hong Kong.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej